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It is generally agreed that the biodurability of man-made vitreous fibers is a major factor for the
characterization of potential health effects. As there is currently no standardization of
experimental protocols to determine biodurability, the results of the clearance assays have not
been used up to now for regulatory purposes. Methods used to analyze biodurability in animal
models are short-term inhalational exposure and intratracheal instillation of rat respirable fibers.
Both test methods have strengths and limitations for regulatory purposes. We outline
recommended procedures for standardized biodurability assays that can be used to compare
different fiber types. In animal experiments, biodurability is difficult to separate from
biopersistence, as mucociliary and macrophage-mediated clearance occur simultaneously with
dissolution and disintegration. For intratracheal instillation, a sized rat respirable sample must be
used. Precautions should be taken to prevent aggregation of fibers in the lungs. Although from a
scientific point of view questions remain about quantifying the influence of fiber length, diameter,
dose, and exposure route, consistent data on the biodurability ofvitreous glass fibers are available
which may be used for regulatory purposes. Environ Health Perspect 105(Suppl 5):1045-1047
(1997)
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Introduction
It is generally agreed that the biodurability
ofman-made vitreous fibers (MMVF) is a
major factor for the characterization of
potential health effects (1). According to
this working hypothesis, faster removal of
MMVF from lungs leads to a decreased risk
offiber-induced health effects. As there is
currently alackofstandardizedexperimental
protocols to determine biodurability, the
results ofclearance kinetics have not yet
been used for regulatory purposes.
It should be noted that the definition of
biodurability differs from that ofbiopersis-
tence. Biopersistence is defined as the ability
ofafiber to remain inthelungin spiteofthe
lung's physiological clearance mechanisms.
These defense mechanisms are a) transporta-
tion ofentire particles by the mucociliary
escalator and by alveolar macrophages, b)
dissolution offibers, and c) disintegration.
Biodurabiity indudes only the removal
offibers from lungs by dissolution and dis-
integration. Biopersistence and biodurabil-
ity offibers are often used as synonyms,
which leads to misunderstandings. Fibers
that persist in the lung for long periods of
time have to be durable, but durable fibers
can be removed from the lungs by physical
transportation, e.g., by ciliary clearance and
macrophage-mediated dearance. In animal
experiments, biodurability offibers is diffi-
cult to determine, as the physical removal
ofentire fibers is also involved. For risk
assessment, however, focus should be on
biodurability and not on biopersistence, as
the fraction offibers removed by physical
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transportation may differ in experimental
animals, compared to humans.
Toxicokinetics of Fibers
Fibers differ from nonfibrous particulates
in their deposition probabilities at various
surfaces ofthe respiratory tract. They may
also have different retention times at depo-
sition sites, as well as different clearance
pathways (1,2).
Deposition
Deposition oflong MMVF primarilyoccurs
in rats in theciliatedairways (3). Theauthors
conduded from theircalculation that, in rats,
afiberhavingadiameterof1 pmandalength
of20 pm has about a 5-fold higher deposi-
tion fraction in the tracheobronchial region
than in thepulmonaryregion.
Clearance
The fate offibers deposited on surfaces
within the respiratory system depends on
the site ofdeposition and the characteristics
ofthe fibers.
Physical transportation refers to the
movement of the intact fiber along the
epithelial surface from alveoli and terminal
bronchioles to the respiratory bronchioles.
Alveolar macrophages play a dominant role
in this process. The elimination ofdurable
fibers from the lung is dependent on fiber
length, fiber diameter, and fiber mass
retained in the lungs. Alveolar macrophages
can onlycompletelyphagocytize fibers up to
about 10pm inlength, prior to theirremoval
via the ciliated airways (4,5). In addition,
fibers may be translocated a) to the ciliated
epithelium at the terminal bronchioles,
b) into and through the epithelium, or
c) alonglymphaticdrainagepathways.
Dissolution is the process of removal
by dissolving a fiber that is dependent on
the chemical composition ofthe fiber (2).
For vitreous fibers this is a complex process
that includes network dissolution and
leaching the various components such as
alkali ions (6).
Disintegration includes processes such
as the subdivision of fibers into shorter
segments. This may result from local dis-
solution or by building a leached layer
easily removed by a physical process (7).
Processes important for fiber removal
are listed in Figure 1. In a simplistic
approach the clearance of fibers from
lungs may be expressed by first-order
kinetics. This approach may be too simple
for the final evaluation of data, but it is
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Figure 1. Principles of fiber removal from lungs and factors that influence each fiber clearance process.
Abbrevations: m, retained fiber mass; k, clearance rate constant; t, time.
appropriate for the understanding of the
principles this approach.
The overall dearance rate constant k can
be separated into subfractions. kdea, describes
the transportation of fibers by physical
removal from lungs as an entire particle, by
ciliary clearance, macrophage-mediated
clearance, and lymphatic clearance. kdiss
describes the fraction ofdearance that is due
to dissolution, and kdecomp is fiber removal
by breakage and disintegration of fibers.
These three processes are dependent on fiber
characteristics and the exposure regimen.
This dearly shows that conventions must be
found for the measurement ofbiodurabiity.
The physical transportation of fibers
may be species dependent. This distinction
should be considered when comparing rats
to humans.
Test Methods
There are two different principal approaches
published for the analysis ofbiodurability:
a) Short-term inhalation of fibers and a
posttreatment observation period of 6 to
18 months, with serial sacrifices for analysis
of fibers in lungs (8-12); b) Intratracheal
instillation ofsized fibers (rat respirable) of
0.5 to 2 mg per animal and subsequent
analysis (13-15). The dose of 2 mg was
chosen to achieve alung burden in a chronic
inhalation study.
The advantage of a short-term inhala-
tion compared to intratracheal instillation
is more even deposition of fibers in the
respiratory tract. However, calculations of
Yu and Asgharian (3) show that fibers
longer than 20 pm have a relatively high
deposition in the tracheobronchial airways
because of interception. Recent data on
the clearance of isometric particles from
human airways show that ciliary clearance
does not remove all particles after 2 days
(16). This effect may also occur in rats;
therefore, clearance of fibers after short-
term inhalation may be influenced by cil-
iary clearance. After a long-term exposure,
fibers may accumulate in the lung com-
partment with the slowest clearance. It is
not clear whether data obtained after short-
term exposure in rats can be extrapolated
to humans who are exposed chronically.
For regulatory purposes Bernstein et al.
(9) suggested using only clearance data
derived from rat short-term inhalation
studies offibers longer than 20 pm. The
argument for this suggestion is that
macrophage-mediated clearance will not
affect these results, as the fibers are too
long to be removed by macrophages. This
is important to consider in order to measure
biodurability (i.e., removal only by dissolu-
tion and disintegration) and to avoid the
fraction ofremoval by physical clearance.
However, fibers longer than 20 pm show
high deposition in the ciliated airways.
Lehnert and Oberd6rster (17) noted that
the mucous layer in the conducting airways
is absent in some areas. This also indicates
that the results ofbiodurability after short-
term inhalation exposure may be compro-
mised byslowphysical removal processes.
Intratracheal instillation ofrat respirable
fibers may lead to a less even distribution in
the lungs compared to inhalation. The frac-
tion that is deposited in the pulmonary
region is probably higher because the
deposition by interception oflong fibers is
less. In addition, fibers longer than 40 pm
can contribute to the formation ofaggre-
gates in lungs. The technique of intratra-
cheal instillation should be validated by
lung examination using scanning electron
microscopy. One technical advantage ofthe
intratracheal instillation method is that the
amount ofsized fibers to be used is less (by
a factor of50), compared to the short-term
inhalation assay. Macrophage-mediated
clearance may be significantly reduced at a
lung burden ofabout 1 mg offibers (11).
However, the instillation of 1 or 2 mg of
fibers induces inflammatory reactions in the
lung, which may change the flow offluids
responsible forfiber dissolution.
Further keyissues that must be addressed
for regulatory purposes are
* The removal of fibers from the lung
depends on fiber diameter. Rat inhalable
fibers are thinner compared to human
inhalable fibers. In rat studies, different
diameters of various fibers were used
although they were sized to achieve a
similar diameter. It is an open question
whether a correction factor should be
applied for the different diameters.
* The retained dose may influence
macrophage-mediated clearance (Figure
1). Although in intratracheal instillation
studies, the same dose (e.g., 2 mg) is
given to rats, the retained dose mayvary
at the first sacrifice date for fibers with
relatively fast dissolution. A correction
factor for differences in the retained
dose is under discussion but currently
no satisfactoryapproach is available.
* For comparing in vitro dissolution
results with biodurability data, the
ciliated clearance and macrophage-
mediated clearance should be minimal.
* Information on carcinogenicity (ifavail-
able) must be correlated with results of
biodurabiity to define critical values for
regulation. A critical step is to define
half-times offiber clearance belowwhich
no carcinogenicity can be assumed.
In summary, in short-term inhalation
studies asignificant fraction offibers is cleared
byphysical removaloffibers. Completeness of
short-term clearance oflong fibers deposited
in the tracheobronchial region has not been
confirmed. In the observed overall dearance,
there may be considerable interference with
the dissolution offibers. Dissolution offibers
inlungs is an importantfactor in thepotential
accumulation ofMMVF in human lungs. If
biodurability data are used for regulation of
MMVF, this issueshouldbeconsidered.
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Data from Research and Consulting
Company, Hingen, Switzerland and
Fraunhofer Institute, Hannover, Germany)
are currently being reviewed for use in stan-
dardizing biodurability tests. Important
areas ofconsideration include a) methods
ofapplication offibers, b) role ofdose, c)
influence offiber dimensions on results, d)
counting procedures offibers, and e) math-
ematical evaluation ofdata (e.g., how to
calculate ahalf-time for regulation).
For the 5-day inhalation test for bio-
durability, a biphasic kinetic may be the
best approach, leading to two half-times for
the fast and the slowphase.
Although from a scientific point of
view, there are ongoing questions about
quantifying the influence of fiber dimen-
sions, dose, and exposure route, consistent
data on the biodurability ofvitreous glass
fibers are available that may be used for
regulatorypurposes.
In Germany, MMVF currently are
regulated partly on the basis ofthe chemical
composition of fibers. This approach is
based primarily on correlation between car-
cinogenicity data after ip injection and
chemical composition (18).
In the European Union, both methods
of biodurability studies, short-term
inhalation and intratracheal instillation,
are currently considered to be used for
regulatory purposes.
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